Skip to main content

Free Australian-first app reminds patients when to have eyedrops

2024-02-27 08:52:42

A smartphone eye drop app developed by a junior doctor aims to improve compliance and clinical outcomes by reminding patients and their carers when to instil their eyedrops.

Launched in October, the Sydney Eyedrop planner and reminder application triggers reminders when eye drops are due and also tracks eye drop use. It is designed for the public to promote ophthalmic medication adherence by providing notifications to take eye medications according to their doctor’s advice and was developed to make it easier for them to clarify communication.

Read the whole article here.

Source: Mivision

Date: 29 november 2023

More news

Want to know more about education for nurses and allied health personnel?

Please join the WAEH Community of Practice: Research impact on clinical practice on 27 February 2024. With presenter Tendai Gwenhure, Clinical Educator (Lead for Student Nurse’s/ RTP Nurses), and Roxanne […]

New ISBCS Implementation Manual Released, Accompanied by BICAT-NL Implementation Project Website Launch

The Netherlands is a leading country in providing same-day bilateral cataract surgery as a treatment for cataracts. In a large study (coordinated by the University Eye Clinic Maastricht) involving 865 […]

Same-day bilateral cataract surgery – breaking down the barriers

WAEH Webinar The Netherlands is a leading country in providing same-day bilateral cataract surgery as a treatment for cataracts. In a large study (coordinated by the University Eye Clinic Maastricht) […]

WAEH Webinar about Same-day bilateral cataract surgery – breaking down the barriers

Register now for the WAEH Webinar about Same-day bilateral cataract surgery – breaking down the barriers on 20 December 2023! The Netherlands is a leading country in providing same-day bilateral […]

Study calls for thorough investigation of patients with early signs of retinal vascular disease

News from our member Moorfields  Eye Hospital NHS Foundation Trust, United Kingdom Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk […]